323 related articles for article (PubMed ID: 24700880)
1. Mutations in SLC34A3/NPT2c are associated with kidney stones and nephrocalcinosis.
Dasgupta D; Wee MJ; Reyes M; Li Y; Simm PJ; Sharma A; Schlingmann KP; Janner M; Biggin A; Lazier J; Gessner M; Chrysis D; Tuchman S; Baluarte HJ; Levine MA; Tiosano D; Insogna K; Hanley DA; Carpenter TO; Ichikawa S; Hoppe B; Konrad M; Sävendahl L; Munns CF; Lee H; Jüppner H; Bergwitz C
J Am Soc Nephrol; 2014 Oct; 25(10):2366-75. PubMed ID: 24700880
[TBL] [Abstract][Full Text] [Related]
2. Hereditary hypophosphatemic rickets with hypercalciuria: pathophysiology, clinical presentation, diagnosis and therapy.
Bergwitz C; Miyamoto KI
Pflugers Arch; 2019 Jan; 471(1):149-163. PubMed ID: 30109410
[TBL] [Abstract][Full Text] [Related]
3. Novel NaPi-IIc mutations causing HHRH and idiopathic hypercalciuria in several unrelated families: long-term follow-up in one kindred.
Yu Y; Sanderson SR; Reyes M; Sharma A; Dunbar N; Srivastava T; Jüppner H; Bergwitz C
Bone; 2012 May; 50(5):1100-6. PubMed ID: 22387237
[TBL] [Abstract][Full Text] [Related]
4. An update on clinical presentation and responses to therapy of patients with hereditary hypophosphatemic rickets with hypercalciuria (HHRH).
Zhu Z; Bo-Ran Ho B; Chen A; Amrhein J; Apetrei A; Carpenter TO; Lazaretti-Castro M; Colazo JM; McCrystal Dahir K; Geßner M; Gurevich E; Heier CA; Simmons JH; Hunley TE; Hoppe B; Jacobsen C; Kouri A; Ma N; Majumdar S; Molin A; Nokoff N; Ott SM; Peña HG; Santos F; Tebben P; Topor LS; Deng Y; Bergwitz C
Kidney Int; 2024 May; 105(5):1058-1076. PubMed ID: 38364990
[TBL] [Abstract][Full Text] [Related]
5. Hypophosphatemic rickets with hypercalciuria due to mutation in SLC34A3/NaPi-IIc can be masked by vitamin D deficiency and can be associated with renal calcifications.
Kremke B; Bergwitz C; Ahrens W; Schütt S; Schumacher M; Wagner V; Holterhus PM; Jüppner H; Hiort O
Exp Clin Endocrinol Diabetes; 2009 Feb; 117(2):49-56. PubMed ID: 18523928
[TBL] [Abstract][Full Text] [Related]
6. Clinical Spectrum of Hereditary Hypophosphatemic Rickets With Hypercalciuria (HHRH).
Stürznickel J; Heider F; Delsmann A; Gödel M; Grünhagen J; Huber TB; Kornak U; Amling M; Oheim R
J Bone Miner Res; 2022 Aug; 37(8):1580-1591. PubMed ID: 35689455
[TBL] [Abstract][Full Text] [Related]
7. Late-onset hereditary hypophosphatemic rickets with hypercalciuria (HHRH) due to mutation of SLC34A3/NPT2c.
Dhir G; Li D; Hakonarson H; Levine MA
Bone; 2017 Apr; 97():15-19. PubMed ID: 27939817
[TBL] [Abstract][Full Text] [Related]
8. Hypophosphatemic rickets with hypercalciuria due to mutation in SLC34A3/type IIc sodium-phosphate cotransporter: presentation as hypercalciuria and nephrolithiasis.
Tencza AL; Ichikawa S; Dang A; Kenagy D; McCarthy E; Econs MJ; Levine MA
J Clin Endocrinol Metab; 2009 Nov; 94(11):4433-8. PubMed ID: 19820004
[TBL] [Abstract][Full Text] [Related]
9. Evaluating pathogenicity of SLC34A3-Ser192Leu, a frequent European missense variant in disorders of renal phosphate wasting.
Schönauer R; Petzold F; Lucinescu W; Seidel A; Müller L; Neuber S; Bergmann C; Sayer JA; Werner A; Halbritter J
Urolithiasis; 2019 Dec; 47(6):511-519. PubMed ID: 30798342
[TBL] [Abstract][Full Text] [Related]
10. Association between compound heterozygous mutations of SLC34A3 and hypercalciuria.
Abe Y; Nagasaki K; Watanabe T; Abe T; Fukami M
Horm Res Paediatr; 2014; 82(1):65-71. PubMed ID: 24924704
[TBL] [Abstract][Full Text] [Related]
11. SLC34A3 mutations in patients with hereditary hypophosphatemic rickets with hypercalciuria predict a key role for the sodium-phosphate cotransporter NaPi-IIc in maintaining phosphate homeostasis.
Bergwitz C; Roslin NM; Tieder M; Loredo-Osti JC; Bastepe M; Abu-Zahra H; Frappier D; Burkett K; Carpenter TO; Anderson D; Garabedian M; Sermet I; Fujiwara TM; Morgan K; Tenenhouse HS; Juppner H
Am J Hum Genet; 2006 Feb; 78(2):179-92. PubMed ID: 16358214
[TBL] [Abstract][Full Text] [Related]
12. A compound heterozygous mutation in SLC34A3 causes hereditary hypophosphatemic rickets with hypercalciuria in a Chinese patient.
Chi Y; Zhao Z; He X; Sun Y; Jiang Y; Li M; Wang O; Xing X; Sun AY; Zhou X; Meng X; Xia W
Bone; 2014 Feb; 59():114-21. PubMed ID: 24246249
[TBL] [Abstract][Full Text] [Related]
13. Hereditary hypophosphatemic rickets with hypercalciuria: case report.
Areses-Trapote R; López-García JA; Ubetagoyena-Arrieta M; Eizaguirre A; Sáez-Villaverde R
Nefrologia; 2012 Jul; 32(4):529-34. PubMed ID: 22806288
[TBL] [Abstract][Full Text] [Related]
14. Digenic Heterozygous Mutations in SLC34A3 and SLC34A1 Cause Dominant Hypophosphatemic Rickets with Hypercalciuria.
Gordon RJ; Li D; Doyle D; Zaritsky J; Levine MA
J Clin Endocrinol Metab; 2020 Jul; 105(7):2392-400. PubMed ID: 32311027
[TBL] [Abstract][Full Text] [Related]
15. Intronic deletions in the SLC34A3 gene cause hereditary hypophosphatemic rickets with hypercalciuria.
Ichikawa S; Sorenson AH; Imel EA; Friedman NE; Gertner JM; Econs MJ
J Clin Endocrinol Metab; 2006 Oct; 91(10):4022-7. PubMed ID: 16849419
[TBL] [Abstract][Full Text] [Related]
16. Fluconazole as a New Therapeutic Tool to Manage Patients With NPTIIc (SLC34A3) Mutation: A Case Report.
Bertholet-Thomas A; Tram N; Dubourg L; Lemoine S; Molin A; Bacchetta J
Am J Kidney Dis; 2019 Jun; 73(6):886-889. PubMed ID: 30765103
[TBL] [Abstract][Full Text] [Related]
17. [Updates on rickets and osteomalacia: the role of NaPi-2c/SLC34A3 and hypophosphataemic rickets].
Segawa H; Shiozaki Y; Minoshima S; Miyamoto K
Clin Calcium; 2013 Oct; 23(10):1445-50. PubMed ID: 24076642
[TBL] [Abstract][Full Text] [Related]
18.
Hasani-Ranjbar S; Ejtahed HS; Amoli MM; Bitarafan F; Qorbani M; Soltani A; Yarjoo B
J Clin Res Pediatr Endocrinol; 2018 Nov; 10(4):343-349. PubMed ID: 29809158
[TBL] [Abstract][Full Text] [Related]
19. SLC34A3 intronic deletion in a new kindred with hereditary hypophosphatemic rickets with hypercalciuria.
Hasani-Ranjbar S; Amoli MM; Ebrahim-Habibi A; Dehghan E; Soltani A; Amiri P; Larijani B
J Clin Res Pediatr Endocrinol; 2012 Jun; 4(2):89-93. PubMed ID: 22672866
[TBL] [Abstract][Full Text] [Related]
20. Hereditary Hypophosphatemic Rickets with Hypercalciuria Presenting with Enthesopathy, Renal Cysts, and High Serum c-Terminal FGF23: Single-Center Experience and Systematic Review.
Dodamani MH; Memon SS; Karlekar M; Lila AR; Khan M; Sarathi V; Arya S; Jamale T; Thakare S; Patil VA; Shah NS; Bergwitz C; Bandgar TR
Calcif Tissue Int; 2024 Feb; 114(2):137-146. PubMed ID: 37981601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
